TCM
TCG Crossover Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-529,839
| Closed | -$5.49M | – | 27 |
|
|
2023
Q2 | $5.49M | Hold |
529,839
| – | – | 0.9% | 20 |
|
|
2023
Q1 | $4.29M | Sell |
529,839
-615,100
| -54% | -$4.98M | 0.84% | 19 |
|
|
2022
Q4 | $18M | Hold |
1,144,939
| – | – | 3.18% | 12 |
|
|
2022
Q3 | $18M | Hold |
1,144,939
| – | – | 5.41% | 8 |
|
|
2022
Q2 | $16M | Hold |
1,144,939
| – | – | 6.79% | 6 |
|
|
2022
Q1 | $19.7M | Buy |
1,144,939
+62,726
| +6% | +$1.08M | 7.92% | 4 |
|
|
2021
Q4 | $15.7M | Buy |
+1,082,213
| New | +$15.7M | 7.37% | 6 |
|